Literature DB >> 20068155

Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases.

Yongming Li1, Xia Li, Bin Guo.   

Abstract

3,3'-Diindolylmethane (DIM) is an anticancer agent that induces cell cycle arrest and apoptosis through unknown mechanisms. Here, we report that DIM can selectively induce proteasome-mediated degradation of class I histone deacetylases (HDAC1, HDAC2, HDAC3, and HDAC8) without affecting the class II HDAC proteins. DIM induced downregulation of class I HDACs in human colon cancer cells in vitro and in vivo in tumor xenografts. HDAC depletion relieved HDAC-mediated transcriptional inhibition of the cyclin-dependent kinase inhibitors p21WAF1 and p27KIP2, significantly increasing their expression and triggering cell cycle arrest in the G(2) phase of the cell cycle. Additionally, HDAC depletion was associated with an induction of DNA damage that triggered apoptosis. Our findings indicate that DIM acts to selectively target the degradation of class I HDACs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20068155      PMCID: PMC2808120          DOI: 10.1158/0008-5472.CAN-09-1924

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

Review 1.  Enhanced histone acetylation and transcription: a dynamic perspective.

Authors:  Alison L Clayton; Catherine A Hazzalin; Louis C Mahadevan
Journal:  Mol Cell       Date:  2006-08-04       Impact factor: 17.970

2.  HDAC inhibitors overcome first hurdle.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2007-01-05       Impact factor: 54.908

3.  Vorinostat.

Authors:  Steven Grant; Chris Easley; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2007-01       Impact factor: 84.694

4.  Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.

Authors:  Dejuan Kong; Yiwei Li; Zhiwei Wang; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.

Authors:  Mohammad M R Bhuiyan; Yiwei Li; Sanjeev Banerjee; Fakhara Ahmed; Zhiwei Wang; Shadan Ali; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

6.  Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway.

Authors:  Yael Ziv; Dana Bielopolski; Yaron Galanty; Claudia Lukas; Yoichi Taya; David C Schultz; Jiri Lukas; Simon Bekker-Jensen; Jiri Bartek; Yosef Shiloh
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

7.  3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells.

Authors:  Yixuan Gong; Heesook Sohn; Ling Xue; Gary L Firestone; Leonard F Bjeldanes
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

8.  Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.

Authors:  Km Wahidur Rahman; Yiwei Li; Zhiwei Wang; Sarah H Sarkar; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

9.  Fas-mediated apoptosis in cholangiocarcinoma cells is enhanced by 3,3'-diindolylmethane through inhibition of AKT signaling and FLICE-like inhibitory protein.

Authors:  Yabing Chen; Jianmin Xu; Nirag Jhala; Pritish Pawar; Zeng B Zhu; Liping Ma; Chang-Hyun Byon; Jay M McDonald
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 10.  Histone deacetylase inhibitors: molecular mechanisms of action.

Authors:  W S Xu; R B Parmigiani; P A Marks
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

View more
  41 in total

1.  Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study.

Authors:  Mitali Pandey; Parminder Kaur; Sanjeev Shukla; Ata Abbas; Pingfu Fu; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

Review 2.  Why AMPK agonists not known to be stressors may surprisingly contribute to miscarriage or hinder IVF/ART.

Authors:  Elizabeth E Puscheck; Alan Bolnick; Awoniyi Awonuga; Yu Yang; Mohammed Abdulhasan; Quanwen Li; Eric Secor; Erica Louden; Maik Hüttemann; Daniel A Rappolee
Journal:  J Assist Reprod Genet       Date:  2018-06-07       Impact factor: 3.412

3.  Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression.

Authors:  Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-05       Impact factor: 4.219

4.  Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.

Authors:  John D Clarke; Anna Hsu; Zhen Yu; Roderick H Dashwood; Emily Ho
Journal:  Mol Nutr Food Res       Date:  2011-03-04       Impact factor: 5.914

5.  3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.

Authors:  Laura M Beaver; Tian-Wei Yu; Elizabeth I Sokolowski; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  Toxicol Appl Pharmacol       Date:  2012-07-16       Impact factor: 4.219

6.  Epigenetic modifications of Nrf2 by 3,3'-diindolylmethane in vitro in TRAMP C1 cell line and in vivo TRAMP prostate tumors.

Authors:  Tien-Yuan Wu; Tin Oo Khor; Zheng-Yuan Su; Constance Lay-Lay Saw; Limin Shu; Ka-Lung Cheung; Ying Huang; Siwang Yu; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2013-05-09       Impact factor: 4.009

Review 7.  Dietary factors and epigenetic regulation for prostate cancer prevention.

Authors:  Emily Ho; Laura M Beaver; David E Williams; Roderick H Dashwood
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

Review 8.  Phytochemicals from cruciferous vegetables, epigenetics, and prostate cancer prevention.

Authors:  Gregory W Watson; Laura M Beaver; David E Williams; Roderick H Dashwood; Emily Ho
Journal:  AAPS J       Date:  2013-06-26       Impact factor: 4.009

Review 9.  Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.

Authors:  Alexander Link; Francesc Balaguer; Ajay Goel
Journal:  Biochem Pharmacol       Date:  2010-06-26       Impact factor: 5.858

Review 10.  Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition.

Authors:  Sharmila Shankar; Dhruv Kumar; Rakesh K Srivastava
Journal:  Pharmacol Ther       Date:  2012-11-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.